Rinvoq — Medica

Initial criteria

• age > 18 years
• Patient has tried or is currently taking a systemic corticosteroid, or systemic corticosteroids are contraindicated
• Medication is prescribed by or in consultation with a rheumatologist

Reauthorization criteria

• Patient has been established on therapy for at least 6 months
• When assessed by at least one objective measure, patient experienced a beneficial clinical response from baseline OR compared with baseline, patient experienced an improvement in at least one symptom such as decreased headache, scalp or jaw pain, decreased fatigue, and/or improved vision

Approval duration

initial: 6 months, reauth: 1 year